Large clinical trial finds pirfenidone may help lung function in IPF patients
Sunday, May 17, 2009 - 13:21
in Health & Medicine
A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF.
Read the whole article on Physorg
More from Physorg
Related
- Large clinical trial finds pirfenidone may help lung function in IPF patientsSun, 17 May 2009, 13:42:52 EDT
- Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patientsTue, 7 Jul 2009, 5:28:37 EDT
- A blood substitute's effectiveness and safety addressed in large clinical trialTue, 10 Jun 2008, 19:56:19 EDT
- The risk factors of idiopathic pulmonary fibrosis in HCV patientsThu, 23 Oct 2008, 9:56:53 EDT
- Results from TH-302 clinical trials presented at international lung cancer meetingThu, 6 Aug 2009, 17:30:56 EDT